Compare NVAX & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | OFG |
|---|---|---|
| Founded | 1987 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1996 | 2012 |
| Metric | NVAX | OFG |
|---|---|---|
| Price | $10.90 | $50.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | $14.44 | ★ $56.25 |
| AVG Volume (30 Days) | ★ 6.8M | 306.6K |
| Earning Date | 11-05-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | ★ 309.76 | 8.27 |
| EPS | N/A | ★ 3.97 |
| Revenue | ★ $1,123,479,000.00 | N/A |
| Revenue This Year | N/A | $2.58 |
| Revenue Next Year | N/A | $1.95 |
| P/E Ratio | ★ N/A | $12.97 |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $35.71 |
| 52 Week High | $13.39 | $54.47 |
| Indicator | NVAX | OFG |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 48.17 |
| Support Level | $7.93 | $48.82 |
| Resistance Level | $11.73 | $53.70 |
| Average True Range (ATR) | 0.79 | 1.43 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 70.99 | 33.66 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.